drugset / Trial / NCT00505882
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
In this pilot study we are evaluating the efficacy of pramlintide on preventing weight gain among early onset type 1 diabetes. We are also evaluating the safety and the effects of treatment with pramlintide on early diagnosed type 1 diabetic subjects, especially among pediatric subjects.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramlintide | Peptide | 60 ug | Subcutaneous |
| Background | Insulin Lispro | Protein / enzyme biologic | — | — |
| Background | insulin aspart | Protein / enzyme biologic | — | — |
| Background | insulin glargine | Protein / enzyme biologic | — | — |